Dr. Peter Howard Gorman, MD

Dr. Gorman practices at University of Maryland Rehabilitation & Orthopaedic Institute in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Gorman's NPI, 1700842895, was assigned on April 26, 2006. Dr. Gorman graduated from Ohio State University College of Medicine in 1985. Dr. Gorman holds Maryland license D34800.

Dr. Gorman's primary practice is University of Maryland Rehabilitation & Orthopaedic Institute, at 2200 Kernan Drive, Baltimore, MD 21207 in Baltimore County. The practice phone is (410) 448-6701.

Dr. Gorman's primary practice is University of Maryland Rehabilitation & Orthopaedic Institute in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Gorman is also affiliated with University of Maryland Medical Center. The medical group on file is University of Maryland Neurology Associates, P.A. Dmand AI also links Dr. Gorman to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gorman practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Gorman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Gorman is licensed in Maryland.

CMS data shows 798 Medicare services from Dr. Gorman across 10 procedure codes in 2024, for 168 Medicare patients. Medicare paid $52,028 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 168 Medicare patients who saw Dr. Gorman in 2024. The largest group is under 65, with 66 patients. 74% of them have high blood pressure, and 70% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gorman's median patient age at 60, with 32% women.

In 2024, Dr. Gorman wrote 1,013 Medicare Part D claims for 106 patients. 95% of them were for generic drugs. CMS names the drug for 846 of them, across 22 drugs with 11 or more claims each, at $33,391 in total drug cost. In 2023, CMS named 793 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gorman for performance year 2024, reported as part of a group. Dr. Gorman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Gorman, published from 2010 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Spinal Cord Injuries, Autonomic Dysreflexia and Oxygen Consumption. Dr. Gorman has published most often in J Spinal Cord Med. Dr. Gorman's most frequent co-authors are Paula Richley Geigle, PT, PhD, William Scott, MD and Steven C. Kirshblum, MD.

Dmand AI links Dr. Gorman to 1 clinical trial. Conditions studied include Paraplegia and Quadriplegia.

CMS Open Payments shows 33 general payments to Dr. Gorman from 5 drug and device companies from 2017 to 2025. Honoraria make up the largest share, 45% of the total. Adare Pharmaceuticals, Inc. paid the most, $4,950.

Dr. Gorman graduated from Ohio State University College of Medicine in 1985.